We are live on ! Find out more
Axa

Axa Portfolio holdings

AUM $256M
1-Year Est. Return 25.01%
This Fund
S&P 500
This Quarter Est. Return
+4.95%
1 Year Est. Return
+25.01%
3 Year Est. Return
+86.3%
5 Year Est. Return
+113.69%
10 Year Est. Return
+471.75%
AUM
$33.6B
AUM Growth
+$255M
Cap. Flow
-$824M
Cap. Flow %
-2.45%
Top 10 Hldgs %
29.14%
Holding
1,152
New
97
Increased
418
Reduced
387
Closed
96

Top Buys

Rank Stock Value
1
AMD icon
Advanced Micro Devices
AMD
+$94.4M
2
ELV icon
Elevance Health
ELV
+$74.7M
3
PAYO icon
Payoneer
PAYO
+$71.5M
4
ABT icon
Abbott
ABT
+$64.2M
5
GE icon
GE Aerospace
GE
+$63.5M

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$101M
2
AAPL icon
Apple
AAPL
+$98.8M
3
AMGN icon
Amgen
AMGN
+$85.8M
4
TXN icon
Texas Instruments
TXN
+$80.9M
5
BIIB icon
Biogen
BIIB
+$73M

Sector Composition

Rank Sector Weight
1 Technology 37.8%
2 Healthcare 15.65%
3 Consumer Discretionary 11.06%
4 Financials 8.19%
5 Industrials 7.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TGT icon
301
Target
TGT
$66.3B
$16M 0.05%
107,751
+5,184
+5% +$816K
LVS icon
302
Las Vegas Sands
LVS
$32.2B
$15.9M 0.05%
360,390
-622
-0.2% -$29K
PYPL icon
303
PayPal
PYPL
$50.3B
$15.9M 0.05%
274,410
+4,809
+2% +$306K
LSCC icon
304
Lattice Semiconductor
LSCC
$16B
$15.9M 0.05%
274,572
+11
+0% +$760
FIX icon
305
Comfort Systems
FIX
$53.5B
$15.9M 0.05%
52,138
+11,703
+29% +$3.72M
ARGX icon
306
argenx
ARGX
$55.2B
$15.6M 0.05%
36,372
+20
+0.1% +$7.66K
INFY icon
307
Infosys
INFY
$51B
$15.6M 0.05%
836,630
FDX icon
308
FedEx
FDX
$73B
$15.6M 0.05%
51,944
+4,746
+10% +$1.24M
CASY icon
309
Casey's General Stores
CASY
$32.1B
$15.5M 0.05%
40,677
+5,151
+14% +$1.72M
FAST icon
310
Fastenal
FAST
$54.8B
$15.4M 0.05%
490,786
+16,092
+3% +$543K
FNV icon
311
Franco-Nevada
FNV
$41.3B
$15.3M 0.05%
129,073
-60,659
-32% -$7.37M
INSM icon
312
Insmed
INSM
$22.4B
$15.2M 0.05%
227,118
-61,481
-21% -$2.38M
GLOB icon
313
Globant
GLOB
$1.65B
$15.1M 0.04%
84,606
-5,637
-6% -$994K
XOM icon
314
ExxonMobil
XOM
$650B
$15.1M 0.04%
130,996
+20,475
+19% +$2.38M
MTD icon
315
Mettler-Toledo International
MTD
$28.1B
$15M 0.04%
10,729
-2,825
-21% -$3.86M
RMD icon
316
ResMed
RMD
$31.1B
$14.9M 0.04%
77,765
-26,655
-26% -$5.41M
TMDX icon
317
Transmedics
TMDX
$2.7B
$14.8M 0.04%
98,510
-6,383
-6% -$766K
TOL icon
318
Toll Brothers
TOL
$14B
$14.8M 0.04%
128,805
+34,814
+37% +$4.21M
COO icon
319
Cooper Companies
COO
$14.2B
$14.8M 0.04%
169,837
-6,442
-4% -$601K
OTIS icon
320
Otis Worldwide
OTIS
$27.9B
$14.8M 0.04%
153,535
-14,993
-9% -$1.44M
MANH icon
321
Manhattan Associates
MANH
$12.1B
$14.7M 0.04%
59,688
+3,888
+7% +$882K
CEG icon
322
Constellation Energy
CEG
$92.1B
$14.7M 0.04%
73,501
+4,048
+6% +$826K
CPRT icon
323
Copart
CPRT
$28.5B
$14.7M 0.04%
271,238
-129,590
-32% -$7.07M
F icon
324
Ford
F
$60.9B
$14.6M 0.04%
1,167,399
-857,439
-42% -$10.6M
MIRM icon
325
Mirum Pharmaceuticals
MIRM
$6.56B
$14.6M 0.04%
425,992
-167,794
-28% -$4.4M

Similar funds

Axa's Q2 2024 Portfolio in Review

As of Q2 2024, Axa held 1,152 positions worth $33.6B, up 0.76% from $33.4B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Axa's Q2 2024 filing shows 97 new, 418 increased, 387 reduced and 96 closed positions. Its largest new stake was Ferrovial N.V. Ordinary Shares: 721,967 shares worth $27.8M. The largest sale was UnitedHealth, an estimated $101M.

By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 36% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Axa's largest Q2 2024 buy was Ferrovial N.V. Ordinary Shares: 721,967 shares worth $27.8M.
  • Axa added most to Advanced Micro Devices in Q2 2024, an estimated $94.4M increase.
  • Axa's biggest Q2 2024 reduction was UnitedHealth, cutting an estimated $101M.
  • Axa fully exited Shockwave Medical, Inc. Common Stock in Q2 2024, selling an estimated $46.4M.
  • Axa's ten largest holdings make up 29% of its $33.6B portfolio in Q2 2024.
  • Axa opened 97 new positions and closed 96 in Q2 2024.
  • Axa's portfolio value rose 0.76% quarter-over-quarter to $33.6B.

Based on Axa's 13F filing for Q2 2024, filed 14 Aug 2024.